Easton Pharmaceuticals IncOver The Counter Market:EAPH
- LAST PRICE0.0000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0000
- Day Range
- 52 Week Range
- Volume35,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EAPH |
|---|---|---|
| 12:35 ET | 10000 | 1E-06 |
| 03:08 ET | 10000 | 1E-06 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Easton Pharmaceuticals Inc | 1.3K | 0.0x | --- |
Vaxxinity Inc | 25.4K | 0.0x | --- |
Oncovista Innovative Therapies Inc | 2.4K | 0.0x | --- |
Allon Therapeutics Inc | 14.1K | 0.0x | --- |
VIA Pharmaceuticals Inc | 20.0 | 0.0x | --- |
Regenicin Inc | 15.4K | 0.0x | --- |
Company Information
Easton Pharmaceuticals, Inc. is a development-stage company engaged in various pharmaceutical sectors and others industries. The Company has a transdermal delivery technology (Viorra Delivery Matrix or VDM), which is incorporated in a line of therapeutic over-the-counter (OTC) products. The Company owns topically-delivered drugs and therapeutic/cosmetic healthcare products focused on cancer and other health problems geared towards female sexual dysfunction, wound healing, pain, motion sickness and other conditions. The Company's products are in various stages of commercialization. The Company's products include Nauseasol, which is a motion sickness gel; Skin Renou HA, which is an anti-aging wrinkle cream; Kenestrin Gel, which is a is a pain relief gel; Viorra, which serves as an aid to the relief of female sexual arousal disorder (FSAD); XILIVE, which is an early-stage cancer drug, and FSAD) drug, which includes a water-based complex polymer matrix.
Contact Information
- Headquarters
- 650 Bay StTORONTO, ON, Canada M4W 1A8
- Phone
- 416-619-0291
- Fax
- 416-646-1000
Executives
- President, Chief Executive Officer
- John Adams
- Chief Financial Officer
- Walter Folinski
- Chief Operating Officer
- Neil Mellor
- Senior Vice President, Chief Medical Officer
- Jack Barkin
- Vice President - Marketing
- Susan Whyte
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 1.3B |
Easton Pharmaceuticals Inc does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $0.01 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
